Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-092614
Filing Date
2026-03-05
Accepted
2026-03-05 08:08:06
Documents
97
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K algs-20251231.htm   iXBRL 10-K 3451677
2 EX-4.3 algs-ex4_3.htm EX-4.3 92269
3 EX-23.1 algs-ex23_1.htm EX-23.1 7111
4 EX-31.1 algs-ex31_1.htm EX-31.1 18250
5 EX-31.2 algs-ex31_2.htm EX-31.2 17036
6 EX-32.1 algs-ex32_1.htm EX-32.1 13028
7 EX-32.2 algs-ex32_2.htm EX-32.2 13635
8 GRAPHIC img164651625_0.gif GRAPHIC 32578
9 GRAPHIC img164651625_1.gif GRAPHIC 13477
10 GRAPHIC img164651625_2.gif GRAPHIC 73495
11 GRAPHIC img164651625_3.gif GRAPHIC 53794
12 GRAPHIC img164651625_4.gif GRAPHIC 38253
13 GRAPHIC img164651625_5.gif GRAPHIC 32467
14 GRAPHIC img164651625_6.gif GRAPHIC 85696
15 GRAPHIC img164651625_7.gif GRAPHIC 15623
  Complete submission text file 0001193125-26-092614.txt   14406492

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT algs-20251231.xsd EX-101.SCH 1930088
100 EXTRACTED XBRL INSTANCE DOCUMENT algs-20251231_htm.xml XML 2384603
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39617 | Film No.: 26724251
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)